Sickle Cell Community Town Hall

We're thrilled to invite you to our year-end Virtual Town Hall Meeting on Thursday, November 30th, from 6:00 to 8:00 PM EST. This pivotal session will introduce Fulcrum Therapeutics, which researches an investigational medicine for sickle cell disease, marking a significant stride in treatment advancements.

Embrace this chance to connect globally as we host this event virtually. This session will provide an educational update on an investigational medicine and a Q&A segment. Join Dr. Lakiea Bailey (Executive Director, SCCC) as she hosts the Fulcrum team, Danielle Branch,  Alex Sapir (President and Chief Executive Officer), Bill Engelman (Medical Director, Hematology), and Mel Hayes (Executive VP, Patient Experience) to discuss this new therapy. 

This meeting is open to all interested in sickle cell disease. Please invite peers, friends, and family for an enriching experience. To attend this Town Hall Meeting, register at: https://tinyurl.com/sc3townhall23.